PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Outlook Therapeutics, Inc.
Filed: September 14, 2017
Period of Report: September 14, 2017
Accession Number: 0001571049-17-007879

View Document ↗ View on SEC.gov ↗